BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17959394)

  • 41. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
    Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
    Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.
    Mehta RR; Bratescu L; Graves JM; Hart GD; Shilkaitis A; Green A; Beattie CW; Das Gupta TK
    Anticancer Res; 1992; 12(3):683-92. PubMed ID: 1377894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment and characterisation of two novel breast cancer cell lines.
    Raju Bagadi SA; Kaur J; Ralhan R
    Cell Biol Int; 2008 Jan; 32(1):55-65. PubMed ID: 17959394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer cell lines: friend or foe?
    Burdall SE; Hanby AM; Lansdown MR; Speirs V
    Breast Cancer Res; 2003; 5(2):89-95. PubMed ID: 12631387
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.